Approval · Notice of Compliance 10139 · 2009
IBUCODONE: Notice of Compliance 10139
Issued April 8, 2009
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 10139
- Date
- April 8, 2009
- Company
- Paladin Labs Inc
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Opioid / nsaid combination analgesic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| IBUCODONE | 02242018 | Cancelled Pre Market |
Medicinal ingredients
- IBUPROFEN 200 MG per TAB
- HYDROCODONE BITARTRATE 7.5 MG per TAB